1. Puche, JE, Saiman, Y, Friedman, SL. Hepatic stellate cells and liver fibrosis. Compr Physiol. 2013;3(4):1473–92. doi:10.1002/cphy.c120035.
Google Scholar | Crossref2. Rifkin, D, Sachan, N, Singh, K, Sauber, E, Tellides, G, Ramirez, F. The role of LTBPs in TGF beta signaling. Dev Dyn. Epub 2021 Mar 20. doi:10.1002/dvdy.331.
Google Scholar | Crossref3. Dooley, S, ten Dijke, P. TGF-β in progression of liver disease. Cell Tissue Res. 2012;347(1):245–56. doi:10.1007/s00441-011-1246y.
Google Scholar | Crossref4. Norita, R, Suzuki, Y, Furutani, Y, Takahashi, K, Yoshimatsu, Y, Podyma-Inoue, KA, Watabe, T, Sato, Y. Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling. Cancer Sci. 2017;108(3):419–26. doi:10.1111/cas.13157.
Google Scholar | Crossref5. Shi, M, Zhu, J, Wang, R, Chen, X, Mi, L, Walz, T, Springer, TA. Latent TGF-β structure and activation. Nature. 2011;474(7351):343–9. doi:10.1038/nature10152.
Google Scholar | Crossref6. Campbell, MG, Cormier, A, Ito, S, Seed, RI, Bondesson, AJ, Lou, J, Marks, JD, Baron, JL, Cheng, Y, Nishimura, SL. Cryo-EM reveals integrin-mediated TGF-β activation without release from latent TGF-β. Cell. 2020;180(3):490–501.e16. doi:10.1016/j.cell.2019.12.030.
Google Scholar | Crossref7. Jenkins, G . The role of proteases in transforming growth factor-beta activation. Int J Biochem Cell Biol. 2008;40(6–7):1068–78. doi:10.1016/j.biocel.2007.11.026.
Google Scholar | Crossref8. Hara, M, Matsuura, T, Kojima, S. TGF-β LAP degradation products, a novel biomarker and promising therapeutic target for liver fibrogenesis. In: Nakao, K, Minato, N, Uemoto, S, editors. Innovative medicine: Basic research and development. Tokyo: Springer; 2015. p. 317–25.
Google Scholar | Crossref9. Hara, M, Inoue, I, Yamazaki, Y, Kirita, A, Matsuura, T, Friedman, SL, Rifkin, DB, Kojima, S. L(59) TGF-beta LAP degradation products serve as a promising blood biomarker for liver fibrogenesis in mice. Fibrogenesis Tissue Repair. 2015;8:17. doi:10.1186/s13069-015-0034-9.
Google Scholar | Crossref10. Yokoyama, H, Masaki, T, Inoue, I, Nakamura, M, Mezaki, Y, Saeki, C, Oikawa, T, Saruta, M, Takahashi, H, Ikegami, M, Hano, H, Ikejima, K, Kojima, S, Matsuura, T. Histological and biochemical evaluation of transforming growth factor-beta activation and its clinical significance in patients with chronic liver disease. Heliyon. 2019;5(2):e01231. doi:10.1016/j.heliyon.2019.e01231.
Google Scholar | Crossref11. Hara, M, Kirita, A, Kondo, W, Matsuura, T, Nagatsuma, K, Dohmae, N, Ogawa, S, Imajoh-Ohmi, S, Friedman, SL, Rifkin, DB, Kojima, S. LAP degradation product reflects plasma kallikrein-dependent TGF-beta activation in patients with hepatic fibrosis. SpringerPlus. 2014;3:221. doi:10.1186/2193-1801.
Google Scholar | Crossref | Medline12. Teraoka, R, Hara, M, Kikuta, K, Hirooka, Y, Furutani, Y, Shimosegawa, T, Masamune, A, Kojima, S. Plasma kallikrein-dependent transforming growth factor-beta activation in patients with chronic pancreatitis and pancreatic cancer. Pancreas. 2017;46(3):e20–2. doi:10.1097/mpa.0000000000000736.
Google Scholar | Crossref13. Arias, M, Sauer-Lehnen, S, Treptau, J, Janoschek, N, Theuerkauf, I, Buettner, R, Gressner, AM, Weiskirchen, R. Adenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats. BMC Gastroenterol. 2003;3:29. doi:10.1186/1471-230x.
Google Scholar | Crossref | Medline14. Furutani, Y, Shiozaki-Sato, Y, Hara, M, Sato, Y, Kojima, S. Hepatic fibrosis and angiogenesis after bile duct ligation are endogenously expressed vasohibin-1 independent. Biochem Biophys Res Commun. 2015;463(3):384–8. doi:10.1016/j.bbrc.2015.05.074.
Google Scholar | Crossref15. Konuma, K, Itoh, M, Suganami, T, Kanai, S, Nakagawa, N, Sakai, T, Kawano, H, Hara, M, Kojima, S, Izumi, Y, Ogawa, Y. Eicosapentaenoic acid ameliorates non-alcoholic steatohepatitis in a novel mouse model using melanocortin 4 receptor-deficient mice. PLoS ONE. 2015;10(3):e0121528. doi:10.1371/journal.pone.0121528.
Google Scholar | Crossref16. Li, M, Qin, XY, Furutani, Y, Inoue, I, Sekihara, S, Kagechika, H, Kojima, S. Prevention of acute liver injury by suppressing plasma kallikrein-dependent activation of latent TGF-beta. Biochem Biophys Res Commun. 2018;504(4):857–64. doi:10.1016/j.bbrc.2018.09.026.
Google Scholar | Crossref